Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries

Martin W.G. Brinkhof, Matthias Egger, Andrew Boulle, Margaret May, Mina Hosseinipour, Eduardo Sprinz, Paula Braitstein, François Dabis, Peter Reiss, David R. Bangsberg, Martin Rickenbach, Jose M. Miro, Landon Myer, Amanda Mocroft, Denis Nash, Olivia Keiser, Margaret Pascoe, Stefaan Van Der Borght, Mauro Schechter, Martin Brinkhof

Research output: Contribution to journalArticlepeer-review

46 Scopus citations


We examined the incidence of and risk factors for tuberculosis during the first year of highly active antiretroviral therapy in low-income (4540 patients) and high-income (22,217 patients) countries. Although incidence was much higher in low-income countries, the reduction in the incidence of tuberculosis associated with highly active antiretroviral therapy was similar: the rate ratio for months 7-12 versus months 1-3 was 0.48 (95% confidence interval, 0.36-0.64) in low-income countries and 0.36 (95% confidence interval, 0.26-0.50) in high-income countries. A low CD4 cell count at the start of therapy was the most important risk factor in both settings.

Original languageEnglish (US)
Pages (from-to)1518-1521
Number of pages4
JournalClinical Infectious Diseases
Issue number11
StatePublished - Dec 1 2007
Externally publishedYes

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases


Dive into the research topics of 'Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries'. Together they form a unique fingerprint.

Cite this